Newsletter | March 16, 2026

03.16.26 -- STREAM New Discoveries: AI Drug Development, GMP, Fill‑Finish & More

SPONSOR

Nu-Tek BioSciences is the market leader in 100% animal-origin free peptones and yeast extracts. Our products reduce variability, strengthen supply security, and improve production performance for global biopharmaceutical customers. Our U.S.-based facility supports both standard and custom solutions for cell culture and fermentation applications. Attending DCAT 2026? Schedule time with Nu-Tek’s commercial team during the show to explore how our products and services can support your cell-based manufacturing needs.

Consistent, Reliable, High-Quality Components

Video | West Pharmaceutical Services, Inc.

Discover a premium line of components for vials, prefilled syringes, and cartridge systems developed and refined to provide best-in-class levels of quality, performance, and risk mitigation.

Your Journey To GMP With Emphasis On Linker Payload Development

Webinar | Abzena

Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.

Balancing Speed, Quality, And Digital Transformations

Webinar | AGC Biologics

Explore how CDMOs can leverage strategic agility, scale flexibility, and overcome challenges to drive success in a rapidly evolving pharmaceutical landscape.

Designing Drug Substance Processes For Fill-Finish Compatibility

Webinar | KBI Biopharma

Integrated solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and practical strategies.

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

Video | Life Science Leader

On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global Head at Kite Pharma, a Gilead-owned company focused on curing cancer with cell therapies.

AI Drug Development

Video | Lonza

Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.